The Healthcare Professionals’ Perspective on Impact and Actions Taken Following Severe Infusion Reaction Events in Oncology Centers in Europe

por Kafatos, George, Dube, Sabada, Burdon, Peter, Lowe, Kimberly, Leclerc, Marjorie, Flinois, Alain, Demonty, Gaston
Publicado 2020

Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma

por Peeters, Marc, Forget, Frédéric, Karthaus, Meinolf, Valladares-Ayerbes, Manuel, Zaniboni, Alberto, Demonty, Gaston, Guan, Xuesong, Rivera, Fernando
Publicado 2018

Preventing, identifying, and managing medication-related osteonecrosis of the jaw: a practical guide for nurses and other allied healthcare professionals

por Drudge-Coates, Lawrence, Van den Wyngaert, Tim, Schiødt, Morten, van Muilekom, H. A. M., Demonty, Gaston, Otto, Sven
Publicado 2020

Panitumumab‐based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials

por Modest, Dominik Paul, Rivera, Fernando, Bachet, Jean‐Baptiste, de Braud, Filippo, Pietrantonio, Filippo, Koukakis, Reija, Demonty, Gaston, Douillard, Jean‐Yves
Publicado 2019

Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRC

por Hebart, Holger, Kiehl, Michael, Tomasek, Jiri, Csoszi, Tibor, Koukakis, Reija, Kafatos, George, Kuhn, Anja, Bjorklof, Katja, Demonty, Gaston, Buchler, Tomas
Publicado 2019

Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving...

por Taieb, Julien, Rivera, Fernando, Siena, Salvatore, Karthaus, Meinolf, Valladares-Ayerbes, Manuel, Gallego, Javier, Geissler, Michael, Koukakis, Reija, Demonty, Gaston, Peeters, Marc
Publicado 2017

European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects

por Keppens, Cleo, Dufraing, Kelly, van Krieken, Han J., Siebers, Albert G., Kafatos, George, Lowe, Kimberly, Demonty, Gaston, Dequeker, Elisabeth M. C.
Publicado 2019

Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with...

por Rivera, Fernando, Karthaus, Meinolf, Hecht, J. Randolph, Sevilla, Isabel, Forget, Frédéric, Fasola, Gianpiero, Canon, Jean-Luc, Guan, Xuesong, Demonty, Gaston, Schwartzberg, Lee S.
Publicado 2017

Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma: results from a randomised controlled trial

por Siena, Salvatore, Tabernero, Josep, Bodoky, Gyorgy, Cunningham, David, Rivera, Fernando, Ruff, Paul, Canon, Jean Luc, Koukakis, Reija, Demonty, Gaston, Hechmati, Guy, Douillard, Jean-Yves
Publicado 2016

Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer

por Karthaus, Meinolf, Hofheinz, Ralf-Dieter, Mineur, Laurent, Letocha, Henry, Greil, Richard, Thaler, Josef, Fernebro, Eva, Oliner, Kelly S, Boedigheimer, Michael, Twomey, Brian, Zhang, Ying, Demonty, Gaston, Köhne, Claus-Henning
Publicado 2016

Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review

por Han van Krieken, J., Kafatos, George, Bennett, James, Mineur, Laurent, Tomášek, Jiří, Rouleau, Etienne, Fabian, Pavel, De Maglio, Giovanna, García-Alfonso, Pilar, Aprile, Giuseppe, Parkar, Parijan, Downey, Gerald, Demonty, Gaston, Trojan, Jörg
Publicado 2017